This inventor holds 1 USPTO granted patent. Top assignee: Msd K.k.. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Innovations of Katsumi Aragane in Gene Modification
Introduction
Katsumi Aragane is a notable inventor based in Toyonaka, Japan. He has made significant contributions to the field of genetic engineering, particularly in the study of the MGAT2 gene. His work focuses on developing gene-modified non-human animals that can aid in understanding the functions of this gene in vivo.
Latest Patents
Katsumi Aragane holds a patent for an "Animal having modification in MGAT2 gene." This invention aims to provide a gene-modified non-human animal with an inactivated MGAT2 gene, which is essential for researching the gene's function. The patent also outlines methods for screening compounds that can inhibit the activity of MGAT2, as well as detecting diseases induced by abnormal lipid metabolism based on the expression level or activity of MGAT2. This innovative approach has the potential to prevent or treat diseases related to lipid metabolism.
Career Highlights
Katsumi Aragane is currently employed at MSD K.K., where he continues to advance his research in genetic modifications. His work is pivotal in the ongoing exploration of gene functions and their implications in health and disease.
Collaborations
Katsumi collaborates with esteemed colleagues, including Naomi Murai and Katsuya Ohbuchi. Their combined expertise enhances the research efforts in the field of genetic engineering.
Conclusion
Katsumi Aragane's innovative work in gene modification, particularly concerning the MGAT2 gene, showcases his commitment to advancing scientific knowledge and potential therapeutic applications. His contributions are invaluable in the quest to understand and treat diseases related to lipid metabolism.